Skip to content
Screener

Cencora COR Q3 2026 earnings

Reported August 5, 2026 · Before market open

Revenue$84.8BBeat by $440.3M
Adjusted EPS$4.48Beat by $0.13
Revenue estimate$84.3B
EPS estimate$4.35
“Our third quarter results reflect the power of our pharmaceutical-centric strategy and the continued execution of our team members. Our strong performance and confidence in our outlook enabled us to raise our fiscal 2026 guidance, underscoring the value we deliver for our stakeholders. Our investments in specialty, digital transformation and talent are strengthening our ability to support our customers across the healthcare ecosystem while positioning Cencora for sustainable long-term growth. The capabilities we have built, and the strength of our core businesses provide a solid foundation for continued growth as we close fiscal 2026.”
Robert P. Mauch

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$88.1B
EPS estimate$4.51

Financials

Q3 2026

Income statement

See full
Revenue$84.8B+5.1%
Gross profit$3.6B+24.1%
Operating income$1.1B+29.1%
Net income$763.5M+11.1%
EPS (diluted)$3.94+11.9%

Balance sheet

See full
Cash & equivalents$2.8B+26.1%
Total debt$11.7B+45.7%
Total equity$3.1B+54.1%
Total assets$83.8B+13.3%

Cash flow

See full
Operating cash flow$2.7B+2,329%
CapEx$226.0M+23.4%
Free cash flow$2.4B—

Valuation & ratios

Valuation

as of 08/27/26
See full
Market cap$62.55B+11.0%
Enterprise value$71.46B+15.0%
P/E17.1×—
P/S0.2×0.0×

Profitability

See full
Gross margin4%+0.5pp
Operating margin0.9%0.0pp

Returns & leverage

See full
Debt / equity3.8×-0.2×
Current ratio0.9×0.0×

Segments

By product

See full
Alliance Healthcare$6.6B+6.0%
Animal Health$1.5B+3.3%
Other Healthcare Solutions$1.1B+5.4%
Other non-strategic businesses$733.5M+15.4%

By segment

See full
U.S. Healthcare Solutions$74.9B+4.9%
International Healthcare Solutions$7.7B+5.9%

FAQ

When did Cencora report Q3 2026 earnings?
Cencora (COR) reported Q3 2026 earnings on August 5, 2026 before market open.
What were Cencora's Q3 2026 revenue and EPS?
Cencora reported revenue of $84.8B and adjusted eps of $4.48 for Q3 2026.
Did Cencora beat estimates in Q3 2026?
Revenue beat the consensus estimate of $84.3B by $440.3M. EPS beat the consensus estimate of $4.35 by $0.13.
How did Cencora's Q3 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 5.1% from $80.7B a year earlier.
Where can I find Cencora's Q3 2026 SEC filings?
You can read the 8-K earnings release (0001140859-26-000032) and the 10-Q periodic report (0001140859-26-000034) directly on SEC EDGAR. The filing index links above go to sec.gov.